Multimodality Treatments for Advanced Basal Cell Carcinoma
A CME-certified and MOC Part II Eligible Activity

Credit Area For Credit: Register/Login     View Activity As Guest

Release Date: May 9, 2014          Expiration Date: May 9, 2015



By clicking the View/Register Button you are agreeing that you have read and understood the information on this page.



Program Description


A recent paradigm shift has resulted in an expanded role for surgical oncologists within the multidisciplinary cancer care team for basal cell carcinoma (BCC). Thus, these clinicians need additional education on all recent therapeutic advances in the management of BCC.

It is crucial that surgical oncologists be kept up to date on the mechanisms of action of novel agents, as well as their roles in improving surgical outcomes for patients with BCC and incorporating patient-selection criteria, dosing strategies, and side-effect management. This program will help surgical oncologists understand the role of multimodality therapies in the management of BCC, and will allow them to incorporate recent evidence-based therapeutic regimens into their clinical practices, ultimately leading to improved patient outcomes.


Downloadables


Download (PDF) Program Slides Download (PDF)

Faculty


Sanjiv S. Agarwala, MD (Co-chair)
Professor of Medicine
Chief, Oncology and Hematology
St. Luke's University Hospital and
Temple University
Bethlehem, PA

Read Biography

Merrick Ross, MD (Co-chair)
Professor of Surgery
Chief/Melanoma Section
Department of Surgical Oncology
MD Anderson Cancer Center
Houston, TX

Read Biography

Aleksandar Sekulic, MD, PhD
Assistant Professor of Dermatology
Mayo Clinic in Arizona
Scottsdale, AZ

Read Biography


Target Audience


This activity is intended for surgical oncologists, medical oncologists, radiation oncologists, dermatologists, and other health care professionals who are involved in the care of patients with basal cell carcinoma.


Educational Objectives


At the conclusion of this activity, participants should be able to demonstrate the ability to:

  • Assess multimodality treatment options for patients with advanced BCC
  • Discuss integration of updated clinical practice guidelines for BCC into practice
  • Review efficacy and safety data for novel treatment agents for BCC

Accreditation


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe Oncology. The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


REQUIREMENTS TO EARN CME/MOC CREDIT


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe Oncology. The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

To receive continuing medical education (CME) and MOC Part II certification credit, participants must view the content, successfully complete the self-assessment exam and achieve a minimum score of 75% on the exam. The self-assessment exam includes 4 multiple choice questions. Learners will be asked to read each question, select an answer, and review the corresponding rationale. Learners will be able to review the content and repeat the self-assessment exam as many times as needed. Upon achieving a score of 75% or higher on all of the modules, learners will be asked to complete a post-activity evaluation. A CME/MOC certificate will be available to print upon successful submission of the post-activity evaluation.

The estimated time to complete this entire activity is 1 hour.


Designation Statement


The Potomac Center for Medical Education designates this activity for a maximum of 1.0 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The Maintenance of Certification (MOC) Credit is only for surgeons who are involved in the treatment of patients with cancer. The Potomac Center for Medical Education, under the American Board of Surgery MOC Criteria, has approved this activity for up to 1 MOC Part II certification points.

For questions regarding CME credit, the post-test, or evaluation, please email contact@rockpointe-pcme.com.


DISCLOSURE INFORMATION


Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.

The faculty/steering committee reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Sanjiv S. Agarwala, MD – Speaker: Bristol-Myers Squibb, Genentech, Merck

Merrick I. Ross, MD, FACS – Advisory Board: GlaxoSmithKline, Merck; Speaker: Genomic Health Honorarium, GlaxoSmithKline

Aleksandar Sekulic, MD, PhD – Nothing to disclose

Non-faculty Content Contributors:
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Latha Shivakumar, PhD, CCMEP; Blair St. Amand; Jay Katz, CCMEP; Ashley Marostica: Nothing to disclose


FDA Disclosure


The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.


System Requirements


In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an Adobe Flash Player. The Adobe Flash Player can be downloaded here.

INSTRUCTIONS FOR PARTICIPANTS AND OBTAINING CME CREDIT


There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME activity in its entirety, take the post-test with a score of 75% or greater, and then complete the evaluation. To complete the evaluation online, choose the best answer to each question. The estimated time for completion of this activity is 1.0 hour. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test.


JOINTLY PROVIDED BY


Potomac Center for Medical Education and Rockpointe Oncology

Supported By


This activity is supported by an educational grant from Genentech.


By clicking the View/Register Button you are agreeing that you have read and understood the information on this page.